Menopause News

DENVER — Therapeutic lifestyle modifications, particularly focusing on diet quality, can improve long-term cardiometabolic health for perimenopausal and postmenopausal women, according to a presenter at the Lifestyle Medicine Conference.

Current menopause smartphone apps require more information on osteoporosis, expert input and better quality, functionality and simplicity of use and understanding for the general public, researchers reported.

Postmenopausal women who stopped or never used hormone therapy over a 5-year period experienced a loss in bone density, whereas bone density was maintained for those who continued treatment, researchers reported in Menopause.

NEW ORLEANS — In this video exclusive, Valerie Montgomery Rice, MD, president and CEO of Morehouse School of Medicine, talks about implications for medical education of the recent Supreme Court decision limiting affirmative action.

Women who sought health care for bothersome perimenopausal symptoms reported both positive and negative experiences in interactions with providers, according to results of the Women Living Better survey.

PHILADELPHIA — Medical and recreational cannabis use by midlife women may be “relatively common,” with 6% of those who report use saying they use the drug to address symptoms of menopause, according to a speaker.

In the first years of use, women prescribed conjugated estrogens/bazedoxifene vs. estrogen/progestin for menopausal symptoms may have higher rates of endometrial cancer and endometrial hyperplasia but lower breast cancer rates.

PHILADELPHIA — Nonhormone therapy options for vasomotor symptoms are important considerations for women who are not good candidates for or may not want to initiate hormone therapy, according to a speaker.

PHILADELPHIA — The short-term effects of postmenopausal hormone therapies on the vascular system and the brain may differ from long-term effects and could be influenced by HT formulation and administration route, according to a speaker.

PHILADELPHIA — At 10 years of follow-up, women who had been assigned menopausal hormone therapy in the KEEPS study had cognitive function scores similar to those of women assigned placebo, according to a speaker.